DK514989A - Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler - Google Patents
Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidlerInfo
- Publication number
- DK514989A DK514989A DK514989A DK514989A DK514989A DK 514989 A DK514989 A DK 514989A DK 514989 A DK514989 A DK 514989A DK 514989 A DK514989 A DK 514989A DK 514989 A DK514989 A DK 514989A
- Authority
- DK
- Denmark
- Prior art keywords
- enolesters
- oxindol
- carboxamides
- acyl
- ethers
- Prior art date
Links
- 150000002170 ethers Chemical class 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1988/003658 WO1990004393A1 (en) | 1988-10-18 | 1988-10-18 | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
Publications (2)
Publication Number | Publication Date |
---|---|
DK514989D0 DK514989D0 (da) | 1989-10-17 |
DK514989A true DK514989A (da) | 1990-04-19 |
Family
ID=22208957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK514989A DK514989A (da) | 1988-10-18 | 1989-10-17 | Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler |
Country Status (33)
Country | Link |
---|---|
US (1) | US5118703A (es) |
JP (1) | JPH07597B2 (es) |
KR (1) | KR910007237B1 (es) |
CN (1) | CN1022241C (es) |
AP (1) | AP118A (es) |
AR (1) | AR246519A1 (es) |
AT (1) | ATE125794T1 (es) |
AU (1) | AU606819B2 (es) |
BG (1) | BG50834A3 (es) |
CA (1) | CA1339558C (es) |
CZ (1) | CZ278983B6 (es) |
DD (1) | DD285604A5 (es) |
DK (1) | DK514989A (es) |
EG (1) | EG19887A (es) |
FI (1) | FI95253C (es) |
HU (1) | HU208421B (es) |
IE (1) | IE66586B1 (es) |
IL (1) | IL91960A (es) |
IS (1) | IS1598B (es) |
MA (1) | MA21657A1 (es) |
MX (1) | MX18021A (es) |
MY (1) | MY104238A (es) |
NO (1) | NO178027C (es) |
NZ (1) | NZ231044A (es) |
OA (1) | OA09140A (es) |
PH (1) | PH27554A (es) |
PL (2) | PL163112B1 (es) |
PT (1) | PT92000B (es) |
RO (1) | RO109195B1 (es) |
RU (1) | RU2036905C1 (es) |
SK (1) | SK590689A3 (es) |
WO (1) | WO1990004393A1 (es) |
YU (1) | YU48070B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
PL174312B1 (pl) * | 1992-11-23 | 1998-07-31 | Pfizer | Nowy związek, kwas 4-chloro-5-trójpodstawiony sililo-2-tiofenokarboksylowy |
US5270331A (en) * | 1993-01-26 | 1993-12-14 | Pfizer, Inc. | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
ATE145206T1 (de) * | 1993-02-09 | 1996-11-15 | Pfizer | Oxindol 1-(n-(alkoxycarbonyl)>carboxamide und 1- (n-carboxamido>carboxamide als antiinflammatorische wirkstoffe |
US5449788A (en) * | 1994-01-28 | 1995-09-12 | Catalytica, Inc. | Process for preparing 2-oxindole-1-carboxamides |
CN1094819C (zh) * | 1997-04-30 | 2002-11-27 | 大兴株式会社 | 环状坯料之制造装置 |
EP0984012A3 (en) * | 1998-08-31 | 2001-01-10 | Pfizer Products Inc. | Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties |
JP2003512396A (ja) * | 1999-10-26 | 2003-04-02 | ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター | インドリン化合物を投与することを含む脱毛症の処置方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE558210A (es) * | 1956-06-08 | |||
US3564009A (en) * | 1966-01-13 | 1971-02-16 | Sumitomo Chemical Co | Process for producing 1-acylindole derivatives |
BE756447A (fr) * | 1969-10-15 | 1971-03-22 | Pfizer | Oxindolecarboxamides |
US3923996A (en) * | 1972-07-31 | 1975-12-02 | Sandoz Ag | 3-Substituted-oxindoles in compositions and methods of treating obesity |
IE53102B1 (en) * | 1981-05-12 | 1988-06-22 | Ici Plc | Pharmaceutical spiro-succinimide derivatives |
EP0076606B1 (en) * | 1981-10-06 | 1986-02-05 | Imperial Chemical Industries Plc | Biochemical process |
US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
RO105052B1 (en) * | 1987-02-02 | 1994-12-01 | Pfizer | Producing process for the crystalline sodium salt, anhydre, of 5-chlorine-3-(2-tenoil)-2-oxindol-1-carboxamide |
DE68923673T2 (de) * | 1988-10-18 | 1996-01-18 | Pfizer | Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden. |
US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
-
1988
- 1988-10-18 SK SK5906-89A patent/SK590689A3/sk unknown
- 1988-10-18 HU HU886740A patent/HU208421B/hu not_active IP Right Cessation
- 1988-10-18 US US07/675,883 patent/US5118703A/en not_active Expired - Lifetime
- 1988-10-18 MX MX1802188A patent/MX18021A/es unknown
- 1988-10-18 RO RO147347A patent/RO109195B1/ro unknown
- 1988-10-18 WO PCT/US1988/003658 patent/WO1990004393A1/en active IP Right Grant
-
1989
- 1989-09-20 IS IS3509A patent/IS1598B/is unknown
- 1989-09-28 CA CA000614317A patent/CA1339558C/en not_active Expired - Fee Related
- 1989-10-04 PH PH39329A patent/PH27554A/en unknown
- 1989-10-09 AT AT89310319T patent/ATE125794T1/de active
- 1989-10-12 IL IL9196089A patent/IL91960A/xx not_active IP Right Cessation
- 1989-10-16 PT PT92000A patent/PT92000B/pt not_active IP Right Cessation
- 1989-10-16 YU YU200589A patent/YU48070B/sh unknown
- 1989-10-16 MY MYPI89001415A patent/MY104238A/en unknown
- 1989-10-16 AP APAP/P/1989/000141A patent/AP118A/en active
- 1989-10-16 BG BG090022A patent/BG50834A3/xx unknown
- 1989-10-17 DK DK514989A patent/DK514989A/da not_active Application Discontinuation
- 1989-10-17 NZ NZ231044A patent/NZ231044A/en unknown
- 1989-10-17 AU AU42956/89A patent/AU606819B2/en not_active Ceased
- 1989-10-17 JP JP1270174A patent/JPH07597B2/ja not_active Expired - Lifetime
- 1989-10-17 PL PL89296831A patent/PL163112B1/pl unknown
- 1989-10-17 MA MA21909A patent/MA21657A1/fr unknown
- 1989-10-17 OA OA59665A patent/OA09140A/xx unknown
- 1989-10-17 KR KR1019890014914A patent/KR910007237B1/ko not_active IP Right Cessation
- 1989-10-17 CN CN89107943A patent/CN1022241C/zh not_active Expired - Fee Related
- 1989-10-17 DD DD89333653A patent/DD285604A5/de not_active IP Right Cessation
- 1989-10-17 PL PL89281871A patent/PL162316B1/pl unknown
- 1989-10-17 IE IE333289A patent/IE66586B1/en not_active IP Right Cessation
- 1989-10-17 AR AR89315179A patent/AR246519A1/es active
- 1989-10-18 CZ CS895906A patent/CZ278983B6/cs not_active IP Right Cessation
- 1989-10-18 EG EG49689A patent/EG19887A/xx active
-
1991
- 1991-04-17 RU SU914895525A patent/RU2036905C1/ru active
- 1991-04-17 NO NO911512A patent/NO178027C/no unknown
- 1991-04-17 FI FI911855A patent/FI95253C/fi not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK165730C (da) | Sammensaetning til afgivelse af hydrofobe medikamenter og dennes fremstilling | |
DK51493A (da) | Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel | |
DK495585D0 (da) | Farmaceutisk praeparat med kontrolleret frigivelse og fremgangsmaade til fremstilling af samme | |
DK118791A (da) | 1-benzopyran-4-oner og 2-amino-1,3-benzoxazin-4-oner, deres fremstilling og anvendelse som eller til fremstilling af laegemidler | |
DK189581A (da) | Hidtil ukendte heparinestere der er anvendelige til fremstilling af laegemidler og fremgangsmaader til deres frmstilling | |
DK288785D0 (da) | Benzensulfonamido-derivater til terapeutisk anvendelse og fremgangsmaade til fremstilling af saadanne derivater | |
DK546788D0 (da) | Fremgangsmaade og anordning ti oparbejdning af flyveaske | |
DK535687D0 (da) | Asbestfri friktionsmaterialer og fremgangsmaade til deres fremstilling | |
DK299089A (da) | Anvendelse af prostaglandiner til fremstilling af laegemidler | |
DK537685D0 (da) | Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf | |
DK408786D0 (da) | Fremgangsmaade til fremstilling af vitaminforstadier og vitaminer | |
DK514989D0 (da) | Enolestere og -ethere af 3-acyl-2-oxindol-1-carboxamider og deres anvendelse til fremstilling af laegemidler | |
DK154382A (da) | Hidtil ukendte derivater af 2-piperazinopyrimidin,fremgangsmaader til deres fremstilling og deres anvendelse som laegemidlereller mellemprodukter til fremstilling af laegemidler | |
DK165985C (da) | 1-cytosinderivater, fremgangsmaader til deres fremstilling, samt anvendelse af dem i og til fremstilling af laegemidler | |
DK95489D0 (da) | Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel | |
DK393489D0 (da) | Benzodiazepinforbindelser og fremgangsmaade til deres fremstilling | |
DK221689A (da) | Naturstensplade og fremgangsmaade til fremstilling af naturstensplade | |
DK701588A (da) | N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater | |
DK13989A (da) | Anvendelse af tnf og lt til fremstilling af laegemidler. | |
DK670588D0 (da) | Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet | |
DK170290D0 (da) | Fremgangsmaade til fremstilling af vandoploeseligt primycin og dets komponent samt farmaceutiske praeparater indeholdende dem | |
DK171089D0 (da) | Anvendelse af tetrazolderivater til fremstilling af laegemidler | |
DK68790A (da) | Anvendelse af tripeptidet l-pyroglutamyl-l-histidylglycin til fremstilling af laegemidler | |
DK630089A (da) | Anvendelse af aryloxyalkanoler og estere deraf til fremstilling af farmaceutika til behandling af retrovirusinfektioner | |
DK342287D0 (da) | Protein med prokoagulerende virkning,fremgangsmaade til fremstilling af et saadant protein og farmaceutisk praeparat indeholdende proteinet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |